Manjool Shah, MD
Ophthalmology · Ann Arbor, MINPI 1447576186
Payments from drug & device makers
Across 641 payments — averaging $1162.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$461K
- Alcon$114K
- Glaukos Corporation$86K
- Ivantis, Inc$17K
- NEW World Medical,inc.$16K
- Surgical Specialties Corporation (US), Inc. (dba Corza Medical)$14K
- plus $37K from 12 others
Across 6 payments — averaging $125.85 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$755
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 460 | $460,549 |
| Alcon | 59 | $113,757 |
| Glaukos Corporation | 46 | $85,836 |
| Ivantis, Inc | 8 | $17,364 |
| NEW World Medical,inc. | 24 | $16,212 |
| Surgical Specialties Corporation (US), Inc. (dba Corza Medical) | 1 | $14,332 |
| Nova Eye, Inc. | 5 | $10,309 |
| Bausch & Lomb Americas Inc. | 11 | $9,063 |
| Sight Sciences, Inc. | 7 | $4,330 |
| Microsurgical Technology, Inc. | 2 | $4,000 |
| Beaver-visitec International, Inc. | 3 | $3,869 |
| Ocular Therapeutix, Inc. | 3 | $2,089 |
| Johnson & Johnson Surgical Vision, Inc. | 5 | $1,949 |
| Aerie Pharmaceuticals, Inc. | 1 | $600 |
| Alcon Research LLC | 1 | $500 |
| Carl Zeiss Meditec, Inc. | 2 | $392 |
| Thea Pharma Inc. | 2 | $64 |
| Biotissue Holdings Inc. | 1 | $15 |
How this compares
$745,230 in reported general payments places this provider in the 95th percentile of 674 ophthalmology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Ann Arbor
- Thomas WubbenAnn Arbor$1.2M
- Cagri BesirliAnn Arbor$441K
- Vinay AakaluAnn Arbor$429K
- Shahzad MianAnn Arbor$209K
- Joshua SteinAnn Arbor$200K
- Mark JohnsonAnn Arbor$188K
- David ZacksAnn Arbor$177K
- Thomas GardnerAnn Arbor$156K
- Amanda BicketAnn Arbor$140K
- Shilpa KodatiAnn Arbor$112K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.